Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
Clinical trial NCT00923013 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00923013
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-20
- Primary completion
- 2024-07-15
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.